August 2026 UOG Highlights
The August issue of Ultrasound in Obstetrics & Gynecology includes a systematic review and meta-analysis evaluating fetal cardiac function in growth-restricted fetuses using left and right myocardial performance indices, a prospective study examining the incidence and predictors of hypertension at 5 months postpartum in women with previous gestational diabetes mellitus, an evaluation of whether the ratio of soluble fms-like tyrosine kinase-1 to placental growth factor is associated with hemodynamic changes in ophthalmic artery Doppler in near-term pregnancy and a prospective study externally validating the diagnostic performance of ADNEX model for distinguishing between malignant and benign adnexal masses when used by non-expert ultrasound examiners in general gynecological settings.
July 2026 Special Issue: Congenital Heart Disease Highlights
The July issue of Ultrasound in Obstetrics & Gynecology is a Special Issue on Congenital Heart disease, produced in collaboration with ISUOG’s ongoing global initiative, Every Little Heart Matters, and curated by UOG Editors Prof. Anita Moon-Grady and Dr Taisto Sarkola. This issue includes an evaluation of the Danish prenatal screening program for detection and outcomes of major fetal CHDs, an assessment of the risk of minor CHD in infants conceived via assisted reproductive technology, a registry based case–cohort study investigating outcome of fetal cardiac intervention in hydropic fetuses with CHD and a How To article from the Fetal Heart Society on assessment of ventricular function by fetal echocardiography.
June 2026 UOG Highlights
The June issue of Ultrasound in Obstetrics & Gynecology includes a systematic review evaluating perinatal outcomes following intrauterine transfusion for fetal anemia secondary to fetal or placental tumor, a 7-year national cohort study reporting national epidemiological data on maternal cytomegalovirus infection during pregnancy in France and the impact of evolving screening and management practices, a prospective study assessing the predictive performance of the Fetal Medicine Foundation first-trimester screening algorithm for pre-eclampsia in pregnancies conceived by assisted reproductive technology, after ovulation induction or through spontaneous conception, and a prospective multicenter study reporting primary results of the CANNES trial comparing the diagnostic accuracy of ultrasound, positron-emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for preoperative pelvic lymph node assessment in cervical cancer patients.
May 2026 UOG Highlights
The May issue of Ultrasound in Obstetrics & Gynecology includes a combined cohort analysis evaluating first-trimester prediction and aspirin prevention of preterm pre-eclampsia in women with chronic hypertension, an individual participant data meta-analysis comparing oral misoprostol with vaginal dinoprostone for induction of labor, a prospective longitudinal study assessing maternal hemodynamic profiles in pregnancies at high risk of pre-eclampsia, an international multicenter observational study evaluating the diagnostic performance of the four-step International Deep Endometriosis Analysis protocol for detecting deep endometriosis, and a Consensus Statement from the International Ovarian Tumor Analysis (IOTA) Group updating terms, definitions and measurements for the sonographic assessment of adnexal tumors.
April 2026 UOG Highlights
The April issue of Ultrasound in Obstetrics & Gynecology includes a systematic review and meta-analysis evaluating perinatal and maternal outcomes of extremely early-onset fetal growth restriction, a prospective multicenter cohort study assessing single-cell-based non-invasive prenatal testing for detecting fetal pathogenic microimbalances, a retrospective cohort study investigating the predictive value of gB2-specific antibodies for maternal–fetal transmission following primary cytomegalovirus infection treated with valacyclovir, and a multicenter case–control study developing a radiomics-based ultrasound model for differentiating uterine sarcomas from leiomyomas.





